Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women

Epidemiology and Infection

Volumn 136, Issue 2, 2008, Pages 215-221

  González, Cristina ^a,b   Canals, J ^c   Ortiz, M ^d   Munoz L ^d   Torres, M ^d   Garcia Saiz A ^d   Del Amo, J ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c Foncalent Prison   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CIGARETTE SMOKING; FEMALE; GYNECOLOGIC DISEASE; GYNECOLOGIC INFECTION; HIGH RISK BEHAVIOR; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRISONER; RISK ASSESSMENT; RISK FACTOR; SPAIN; SUPERINFECTION; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; VIRUS TYPING;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREVALENCE; PRISONS; RISK FACTORS; SMOKING; SPAIN; UTERINE CERVICAL NEOPLASMS;

EID: 38049155626     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008382     Document Type: Article

References (22)

1. Globocan 2002. Cancer incidence, mortality and prevalence worldwide (www.dep.iarc.fr/dataava/infodata.htm). Accessed April 2006.
2. Smith PF, et al. HIV infection among women entering the New York State correctional system. American Journal of Public Health 1991; 81 (Suppl.): 35-40.
3. Alonso-Sanz M, et al. Microbiological study of some microorganisms illicated in sexually transmitted diseases female prison population. Enfermedades Infecciosas y Microbiologia Clinica. 1996; 14: 474-478.
4. Blackell NA, et al. Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women. American Journal of Public Health 1991;81: 1318-1320.
5. Lopes F, et al. HIV, HPV; and syphilis prevalence in a women's penitentiary in the city of Sao Paulo, 1997-1998. Cadernos & Satide Pública 2001; 17: 1473-1480.
6. De Sanjosé S, et al. Hum paoillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners. Medicina Clinica (Barcelona) 2000; 115: 81-84.
7. Sotlar K, et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. Journal of clinical Microbiology 2004; 42: 3176-3184.
8. Hassen E, et al. Cervical human papillomavirus infection in Tunisian women. Infection 2003; 31: 143-148.
9. Del Amo J, et al. Prevalence and determinants of high risk human papillomavirus in migrant ana Spanish female sex workers. XXIV Scientific Meeting of the Spanish Society of Epidemiology. Logroño, Spain, 3-6 October 2006. Abstract No. 147.
10. Del Amo J, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sexually Transmitted Infections 2005; 81 79-84.
11. González C, et al. Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain. Sexually Transmitted Infections 2006; 82: 260-262.
12. Ho GY, et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. International Journal of Cancer 1994; 56: 788-792.
13. Sellors JW, et al. Incidence, clearance and predictors of human papillomavirus infection in women. Canadian Medical Association Journal 2002; 107: 871-873.
14. Remartinez EJ, et al Trends in mortality in a Spanish prison from 1994-2004. Revista Española de Salud Pública 2005; 79: 673-682.
15. Palefsky JM, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute 1999; 91: 226-236.
16. Minkoff H, et al. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. American Journal of Obstetrics and Gynecology 1998; 178: 982-986.
17. Ahdieh L, et al. Cervical neoplasia and repeated positivity of human papillomavirus infection in human. immunodeficiency virus seropositive and seronegative women. American Journal of Epidemiology 2000; 151: 1148-1157.
18. Cu-Uvin S, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV) seropositive and high-risk HIV seronegative women. HIV Epidemiology Research Study Group. Clinical Infectious Diseases 1999; 29: 1145-1150.
19. Sun XW, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. New England Journal of Medicine 1997; 337: 1343-1349.
20. Seek AC, et al. Cervical intraepethelial neoplasia, and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV. International Journal of STD & AIDS 1994; 5: 189-193.
21. Fruchter R, et al. Multiple recurrentes of cervical intravenous intraepithelial neoplasia in women with the HIV. American Journal of Obstetrics and Gynecology 1996; 97: 338-344.
22. Six C, et al. Comparative prevalence, incidence, and short-term prognosis of cervical squamous intraepithelial lesion amongst HIV-infected and HIV-uninfected women. AIDS 1998; 12: 1047-1056.